152 related articles for article (PubMed ID: 12395914)
1. Serum levels of glucose-derived advanced glycation end products are associated with the severity of diabetic retinopathy in type 2 diabetic patients without renal dysfunction.
Koga K; Yamagishi S; Okamoto T; Inagaki Y; Amano S; Takeuchi M; Makita Z
Int J Clin Pharmacol Res; 2002; 22(1):13-7. PubMed ID: 12395914
[TBL] [Abstract][Full Text] [Related]
2. Increased serum levels of advanced glycation end-products and diabetic complications.
Ono Y; Aoki S; Ohnishi K; Yasuda T; Kawano K; Tsukada Y
Diabetes Res Clin Pract; 1998 Aug; 41(2):131-7. PubMed ID: 9789719
[TBL] [Abstract][Full Text] [Related]
3. Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy.
Ghanem AA; Elewa A; Arafa LF
Eur J Ophthalmol; 2011; 21(1):48-54. PubMed ID: 20544678
[TBL] [Abstract][Full Text] [Related]
4. Increased serum levels of the specific advanced glycation end product methylglyoxal-derived hydroimidazolone are associated with retinopathy in patients with type 2 diabetes mellitus.
Fosmark DS; Torjesen PA; Kilhovd BK; Berg TJ; Sandvik L; Hanssen KF; Agardh CD; Agardh E
Metabolism; 2006 Feb; 55(2):232-6. PubMed ID: 16423631
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes.
Miura J; Yamagishi Si; Uchigata Y; Takeuchi M; Yamamoto H; Makita Z; Iwamoto Y
J Diabetes Complications; 2003; 17(1):16-21. PubMed ID: 12505751
[TBL] [Abstract][Full Text] [Related]
6. Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes.
Aso Y; Inukai T; Tayama K; Takemura Y
Acta Diabetol; 2000; 37(2):87-92. PubMed ID: 11194933
[TBL] [Abstract][Full Text] [Related]
7. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.
Tan KC; Shiu SW; Chow WS; Leng L; Bucala R; Betteridge DJ
Diabetologia; 2006 Nov; 49(11):2756-62. PubMed ID: 16969649
[TBL] [Abstract][Full Text] [Related]
8. Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo.
Takeuchi M; Makita Z; Bucala R; Suzuki T; Koike T; Kameda Y
Mol Med; 2000 Feb; 6(2):114-25. PubMed ID: 10859028
[TBL] [Abstract][Full Text] [Related]
9. Relationship between blood levels of N-carboxymethyl-lysine and pentosidine and the severity of microangiopathy in type 2 diabetes.
Hirata K; Kubo K
Endocr J; 2004 Dec; 51(6):537-44. PubMed ID: 15644571
[TBL] [Abstract][Full Text] [Related]
10. Correlation Between Vitreous Advanced Glycation End Products, and D-dimer with Blood HbA1c Levels in Proliferative Diabetic Retinopathy.
Loho T; Venna V; Setiabudy RD; Sukartini N; Immanuel S; Kumalawati J; Victor AA; Waspadji S
Acta Med Indones; 2018 Apr; 50(2):132-137. PubMed ID: 29950532
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of AGE peptides in type 1 diabetic patients are associated with serum creatinine and not with albumin excretion rate: possible role of AGE peptide-associated endothelial dysfunction.
Schalkwijk CG; Ter Wee PM; Stehouwer CD
Ann N Y Acad Sci; 2005 Jun; 1043():662-70. PubMed ID: 16037290
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products in adolescents and young adults with diabetic angiopathy.
Chiarelli F; Catino M; Tumini S; Cipollone F; Mezzetti A; Vanelli M; Verrotti A
Pediatr Nephrol; 2000 Aug; 14(8-9):841-6. PubMed ID: 10955941
[TBL] [Abstract][Full Text] [Related]
13. Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries.
Schalkwijk CG; Ligtvoet N; Twaalfhoven H; Jager A; Blaauwgeers HG; Schlingemann RO; Tarnow L; Parving HH; Stehouwer CD; van Hinsbergh VW
Diabetes; 1999 Dec; 48(12):2446-53. PubMed ID: 10580435
[TBL] [Abstract][Full Text] [Related]
14. Association analysis of -429T/C receptor for advanced glycation end products (RAGE) gene polymorphism with type 2 diabetic retinopathy and serum soluble RAGE levels in Pakistani patients.
Qayyum S; Afzal M; Naveed AK
J Pak Med Assoc; 2021 Apr; 71(4):1175-1180. PubMed ID: 34125766
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of N(ε)- Carboxy methyl lysine (N(ε)-CML) are associated with topographic alterations in retinal pigment epithelium: A preliminary study.
Mishra N; Saxena S; Ruia S; Prasad S; Singh V; Khanna V; Staffa R; Gaspar L; Kruzliak P
J Diabetes Complications; 2016 Jul; 30(5):868-72. PubMed ID: 27039312
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes.
Berg TJ; Snorgaard O; Faber J; Torjesen PA; Hildebrandt P; Mehlsen J; Hanssen KF
Diabetes Care; 1999 Jul; 22(7):1186-90. PubMed ID: 10388987
[TBL] [Abstract][Full Text] [Related]
17. Comparison of advanced glycation endproducts on haemoglobin (Hb-AGE) and haemoglobin A1c for the assessment of diabetic control.
Turk Z; Mesić R; Benko B
Clin Chim Acta; 1998 Oct; 277(2):159-70. PubMed ID: 9853699
[TBL] [Abstract][Full Text] [Related]
18. Role of N-ε- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus.
Choudhuri S; Dutta D; Sen A; Chowdhury IH; Mitra B; Mondal LK; Saha A; Bhadhuri G; Bhattacharya B
Mol Vis; 2013; 19():100-13. PubMed ID: 23378723
[TBL] [Abstract][Full Text] [Related]
19. Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Nepsilon-(carboxymethyl) lysine independently of glycohaemoglobin concentrations.
Hammes HP; Brownlee M; Lin J; Schleicher E; Bretzel RG
Diabetologia; 1999 May; 42(5):603-7. PubMed ID: 10333054
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycation index and its association with severity of diabetic retinopathy in type 2 diabetic subjects.
Anitha B; Sampathkumar R; Balasubramanyam M; Rema M
J Diabetes Complications; 2008; 22(4):261-6. PubMed ID: 18413194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
